A year and a half after Cellarity raised $123M, the Flagship biotech is back — and it's ready to pick out candidates

Cellarity doesn’t have any lead candidates yet. It doesn’t even have a public pipeline.

But it’s still attracting new investors. In a third round of …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

A year and a half af­ter Cel­lar­i­ty raised $123M, the Flag­ship biotech is back — and it's ready to pick out can­di­dates